These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26548494)

  • 41. Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus.
    Shah M; Garg J; Patel B; Guthier J; Freudenberger RS
    Int J Cardiol; 2016 Jul; 215():129-31. PubMed ID: 27111175
    [No Abstract]   [Full Text] [Related]  

  • 42. [Synthetic cannabinoids: A new addiction matrix].
    Scocard A; Benyamina A; Coscas S; Karila L
    Presse Med; 2017 Jan; 46(1):11-22. PubMed ID: 28063756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comment: Spice, reversible cerebral vasoconstriction, and intracranial hemorrhage.
    Barber PA
    Neurology; 2015 Sep; 85(13):1179. PubMed ID: 26320205
    [No Abstract]   [Full Text] [Related]  

  • 44. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence.
    Ninnemann AL; Lechner WV; Borges A; Lejuez CW
    Addict Behav; 2016 Dec; 63():72-3. PubMed ID: 27424166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
    Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bath salts and other emerging toxins.
    Thornton MD; Baum CR
    Pediatr Emerg Care; 2014 Jan; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic cannabinoids and potential reproductive consequences.
    Sun X; Dey SK
    Life Sci; 2014 Feb; 97(1):72-7. PubMed ID: 23827241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How much can synthetic cannabinoid damage the heart? A case of cardiogenic shock following resistant ventricular fibrillation after synthetic cannabinoid use.
    Yamanoglu A; Celebi Yamanoglu NG; Evran T; Sogut O
    J Clin Ultrasound; 2018 Nov; 46(9):605-609. PubMed ID: 29479764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
    Mörkl S; Blesl C; Wurm WE; Tmava A
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum.
    Bilgrei OR
    Int J Drug Policy; 2016 Mar; 29():1-8. PubMed ID: 26860324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. K2 and Spice use among a cohort of college students in southeast region of the USA.
    Egan KL; Suerken CK; Reboussin BA; Spangler J; Wagoner KG; Sutfin EL; Debinski B; Wolfson M
    Am J Drug Alcohol Abuse; 2015; 41(4):317-22. PubMed ID: 26030768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.